Alternatives
Alternatives to Found
Found scores 92/100 on our Cost-Efficiency Index . Here are other programs to consider, each scored the same way. Partners are listed first.
Found at a glance
- Semaglutide
- $199/moInsurance-linked
- Tirzepatide
- $289/moInsurance-linked
- Coverage
- All 50 states
- Brand-name GLP-1s
- Yes
- Oral option
- Yes
- Pricing verified
- October 2026
5 of the 8 programs below list semaglutide for less than Found's $199 a month. 5 of the 8 list tirzepatide for less than its $289 a month.
Found bundles compounded semaglutide or tirzepatide into a care plan you can pay for with insurance or cash; month to month, semaglutide is $199 insured or $289 cash.
Best for: Insured shoppers who want clinician visits billed through their plan, and anyone who wants a coached program with brand-name drugs available if they need them.
What Found does well
- Two ways to pay: with insurance you see a clinician by video for your copay, usually about $30, and with cash pay care is mostly by text with no copay
- Compounded medication is included in the plan price on both tracks, at the same price at every dose
- Longer plans lower the price per cycle: insured semaglutide falls from $199 to $159, $129 and $99 on three, six and twelve months
- Brand-name Wegovy, Zepbound and Ozempic and the Foundayo pill are available too, billed separately from the plan
- Every plan includes a personalized care plan, lifestyle and habit coaching from licensed clinicians, and a member community
- You can switch plans at any time through support, and new members get $100 off the first month on most plans
Why readers look for an alternative
- The $99 headline is the insured price on a twelve-month plan paid up front; one month at a time is $199 insured or $289 cash
- Tirzepatide costs more: $289 a month with insurance and $359 with cash, or $179 and $239 a month on a prepaid year
- Plans bill every 28 days, so a year is 13 charges rather than 12
- Missing a scheduled video visit without 24 hours' notice costs a $30 no-show fee
- Brand-name drugs cost far more than the plan: Found lists Ozempic at about $1,100 a month and Wegovy or Zepbound from $650
- Partner01A94/ 100Index
CoreAge Rx
CoreAge Rx charges one flat price at every dose, $99 a month for semaglutide and $149 for tirzepatide, with no membership fee.
- Sema
- $99/mo
- Tirz
- $149/mo
- Coverage
- All 50 states
- Brand
- Compounded
Compared with Found: $100/mo less for semaglutide · $140/mo less for tirzepatide · compounded only, no brand-name GLP-1s · no oral option
- 02A94/ 100Index
Eden
PartnerEden charges $99 a month for compounded semaglutide and $129 for compounded tirzepatide, the same at every dose, with the visit, medication and shipping included.
- Sema
- $99/moAll doses, compounded
- Tirz
- $129/moAll doses, compounded
- Coverage
- All 50 states
- Brand
- Yes
Compared with Found: $100/mo less for semaglutide · $160/mo less for tirzepatide · no oral option
Regulatory note: the FDA issued a warning letter to Eden Health International Inc. dba Eden in June 2026. We still list and link to Eden; you should know the letter is on the public record before you decide.
- 03B+87/ 100Index
ShedRx (Shed)
PartnerShed sells its GLP-1s as an injection, drops, lozenges or a daily pill, with brand-name Zepbound too; month to month, semaglutide is $199 and tirzepatide $299.
- Sema
- $199/mo$159 on a 12-month plan
- Tirz
- $299/mo$239 on a 12-month plan
- Coverage
- All 50 states
- Brand
- Yes
Compared with Found: $10/mo more for tirzepatide
- 04B+87/ 100Index
Strut Health
PartnerStrut sells compounded semaglutide from $99 a month as a lozenge or $129 as a weekly injection, and tirzepatide from $149, all on auto-refill.
- Sema
- From $99/moLozenge, $129/mo injection (auto-refill)
- Tirz
- From $149/moInjection, $199/mo lozenge (auto-refill)
- Coverage
- Multi-state
- Brand
- Compounded
Compared with Found: $100/mo less for semaglutide · $140/mo less for tirzepatide · compounded only, no brand-name GLP-1s
Regulatory note: the FDA issued a warning letter to Strut Health, LLC dba Strut in February 2026. We still list and link to Strut Health; you should know the letter is on the public record before you decide.
- 05B86/ 100Index
Sesame Care
PartnerSesame sells brand-name GLP-1 care rather than compounded drugs: the care plan runs $59 to $99 a month, and medication such as the Wegovy pill starts at $149 a month on top.
- Sema
- $149/moMedication + $59/mo care subscription (that rate needs a 12-month commitment)
- Tirz
- Brand (Zepbound)
- Coverage
- Nationwide
- Brand
- Yes
- 06B+88/ 100Index
Invigor Medical
Solid mid-market cost on both molecules from an established operator — good value if you also want a broader metabolic and hormone catalog.
- Sema
- $225/moStarting dose
- Tirz
- $350/moStarting dose
- Coverage
- All 50 states
- Brand
- Compounded
Compared with Found: $26/mo more for semaglutide · $61/mo more for tirzepatide · compounded only, no brand-name GLP-1s · no oral option
- 07B+88/ 100Index
Tryozi
Tryozi currently advertises monthly compounded injection enrollment offers of $79 semaglutide or $129 tirzepatide, with all doses included. Its branded options are priced separately.
- Sema
- $79/moCurrent enrollment offer, all doses, compounded; usual price $279
- Tirz
- $129/moCurrent enrollment offer, all doses, compounded; usual price $379
- Coverage
- All 50 states
- Brand
- Yes
Compared with Found: $120/mo less for semaglutide · $160/mo less for tirzepatide · no oral option
- 08B+87/ 100Index
Vitara RX
$99 semaglutide and $149 tirzepatide at every dose, in 49 states (not Alaska) and LegitScript-verified, which undercuts most of the field without dropping a molecule.
- Sema
- $99/mo
- Tirz
- $149/mo
- Coverage
- 49 states
- Brand
- Compounded
Compared with Found: $100/mo less for semaglutide · $140/mo less for tirzepatide · compounded only, no brand-name GLP-1s · no oral option
Assume any provider we list may compensate us — it never changes the Cost-Efficiency Index. Pricing and coverage reflect public disclosures at last review; confirm on each provider's site. Not medical advice. See our disclosure.